Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1955 | 5174 | 29.2 | 73% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
625 | 10024 | KAWASAKI DISEASE//MUCOCUTANEOUS LYMPH NODE SYNDROME//SUPERANTIGEN |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
1417 | 2574 | KAWASAKI DISEASE//MUCOCUTANEOUS LYMPH NODE SYNDROME//KAWASAKI SYNDROME |
5262 | 1581 | SUPERANTIGEN//STAPHYLOCOCCAL ENTEROTOXIN B//SUPERANTIGENS |
10201 | 1019 | TOXIC SHOCK SYNDROME//TOXIC SHOCK SYNDROME TOXIN 1//SPECIAL MAT S |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | KAWASAKI DISEASE | Author keyword | 1600 | 78% | 21% | 1072 |
2 | MUCOCUTANEOUS LYMPH NODE SYNDROME | Author keyword | 221 | 86% | 2% | 112 |
3 | SUPERANTIGEN | Author keyword | 138 | 39% | 5% | 277 |
4 | KAWASAKI SYNDROME | Author keyword | 129 | 79% | 2% | 84 |
5 | CORONARY ARTERY LESIONS | Author keyword | 58 | 80% | 1% | 36 |
6 | TOXIC SHOCK SYNDROME | Author keyword | 58 | 46% | 2% | 94 |
7 | INCOMPLETE KAWASAKI DISEASE | Author keyword | 53 | 95% | 0% | 18 |
8 | CORONARY ARTERY ANEURYSM | Author keyword | 53 | 43% | 2% | 93 |
9 | CORONARY ARTERY ABNORMALITIES | Author keyword | 41 | 81% | 0% | 25 |
10 | SUPERANTIGENS | Author keyword | 40 | 32% | 2% | 104 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | KAWASAKI DISEASE | 1600 | 78% | 21% | 1072 | Search KAWASAKI+DISEASE | Search KAWASAKI+DISEASE |
2 | MUCOCUTANEOUS LYMPH NODE SYNDROME | 221 | 86% | 2% | 112 | Search MUCOCUTANEOUS+LYMPH+NODE+SYNDROME | Search MUCOCUTANEOUS+LYMPH+NODE+SYNDROME |
3 | SUPERANTIGEN | 138 | 39% | 5% | 277 | Search SUPERANTIGEN | Search SUPERANTIGEN |
4 | KAWASAKI SYNDROME | 129 | 79% | 2% | 84 | Search KAWASAKI+SYNDROME | Search KAWASAKI+SYNDROME |
5 | CORONARY ARTERY LESIONS | 58 | 80% | 1% | 36 | Search CORONARY+ARTERY+LESIONS | Search CORONARY+ARTERY+LESIONS |
6 | TOXIC SHOCK SYNDROME | 58 | 46% | 2% | 94 | Search TOXIC+SHOCK+SYNDROME | Search TOXIC+SHOCK+SYNDROME |
7 | INCOMPLETE KAWASAKI DISEASE | 53 | 95% | 0% | 18 | Search INCOMPLETE+KAWASAKI+DISEASE | Search INCOMPLETE+KAWASAKI+DISEASE |
8 | CORONARY ARTERY ANEURYSM | 53 | 43% | 2% | 93 | Search CORONARY+ARTERY+ANEURYSM | Search CORONARY+ARTERY+ANEURYSM |
9 | CORONARY ARTERY ABNORMALITIES | 41 | 81% | 0% | 25 | Search CORONARY+ARTERY+ABNORMALITIES | Search CORONARY+ARTERY+ABNORMALITIES |
10 | SUPERANTIGENS | 40 | 32% | 2% | 104 | Search SUPERANTIGENS | Search SUPERANTIGENS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LYMPH NODE SYNDROME | 519 | 83% | 6% | 288 |
2 | STAPHYLOCOCCAL ENTEROTOXIN A | 153 | 60% | 3% | 166 |
3 | STAPHYLOCOCCAL ENTEROTOXIN B | 139 | 37% | 6% | 298 |
4 | BACTERIAL SUPERANTIGENS | 136 | 57% | 3% | 163 |
5 | CORONARY ARTERY ANEURYSMS | 110 | 74% | 2% | 81 |
6 | TOXIC SHOCK SYNDROME | 109 | 26% | 7% | 368 |
7 | SHOCK SYNDROME TOXIN 1 | 100 | 46% | 3% | 161 |
8 | CORONARY ANEURYSMS | 89 | 90% | 1% | 38 |
9 | ANTIBODY TARGETED SUPERANTIGENS | 76 | 93% | 1% | 28 |
10 | BACTERIAL SUPERANTIGEN | 62 | 57% | 1% | 74 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Diagnosis, treatment, and long-term management of Kawasaki disease - A statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association | 2004 | 531 | 192 | 89% |
Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, Council on Cardiovascular Disease in the Young, American Heart Association | 2004 | 443 | 185 | 89% |
Kawasaki syndrome | 2004 | 321 | 113 | 96% |
Epidemiology of Kawasaki Disease in Asia, Europe, and the United States | 2012 | 47 | 32 | 100% |
Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis | 2013 | 17 | 37 | 100% |
The bacterial superantigen and superantigen-like proteins | 2008 | 179 | 143 | 52% |
Update on etio and immunopathogenesis of Kawasaki disease | 2014 | 7 | 37 | 70% |
Bacterial superantigens | 2003 | 220 | 72 | 61% |
Toxic shock syndrome and bacterial superantigens: An update | 2001 | 320 | 154 | 47% |
Staphylococcal Enterotoxins | 2010 | 59 | 111 | 65% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | KAWASAKI DIS | 21 | 90% | 0.2% | 9 |
2 | INTEGRATED TOXICOL | 3 | 16% | 0.3% | 18 |
3 | FED DIST HLTH | 2 | 67% | 0.0% | 2 |
4 | MED DEVICES DIAGNOST S | 2 | 67% | 0.0% | 2 |
5 | SPECIAL MAT S | 2 | 67% | 0.0% | 2 |
6 | WALLENBERG TUMOR IMMUNOL | 2 | 67% | 0.0% | 2 |
7 | PEDIAT CARDIOL NEPHROL | 2 | 15% | 0.3% | 13 |
8 | GF STRONG S | 2 | 50% | 0.1% | 3 |
9 | PEDIAT 0830 | 2 | 40% | 0.1% | 4 |
10 | PEDIAT ALLERGY IMMUNOL UNIT | 2 | 20% | 0.2% | 9 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000014347 | MAMMARY GLAND//MOUSE MAMMARY TUMOR VIRUS//JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA |
2 | 0.0000011611 | STREPTOCOCCUS SUIS//GROUP A STREPTOCOCCI//STREPTOCOCCUS PYOGENES |
3 | 0.0000010748 | CORONARY ARTERY FISTULA//CORONARY ARTERY ECTASIA//HEMOPTYSIS |
4 | 0.0000009539 | STAPHYLOCOCCUS AUREUS//MRSA//METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS |
5 | 0.0000008714 | INVARIANT CHAIN//CIITA//HLA DM |
6 | 0.0000007190 | CD1D//GAMMA DELTA T CELLS//ALPHA GALACTOSYLCERAMIDE |
7 | 0.0000006062 | WEGENERS GRANULOMATOSIS//GIANT CELL ARTERITIS//VASCULITIS |
8 | 0.0000006026 | COMMON VARIABLE IMMUNODEFICIENCY//PRIMARY IMMUNODEFICIENCY//IGA DEFICIENCY |
9 | 0.0000005871 | EPISTAXIS//SINUS PERICRANII//NASAL PACKING |
10 | 0.0000003992 | MYOCARDIAL BRIDGING//MYOCARDIAL BRIDGE//CORONARY ANOMALIES |